A New Jersey jury has hit the pharmaceutical company that makes Accutane with a $25.16 million judgment in a lawsuit filed by an Alabama man who blamed the drug for his inflammatory bowel disorder.Thirty-eight-year-old Andrew McCarrell of Moody, Ala., took the acne drug in his 20s. He says Hoffmann-La Roche Inc. failed to adequately warn of its side effects. McCarrell eventually had his colon removed.
More...
The U.S. is seeing a late summer surge in COVID-19 cases, tracking from the Centers for...
The US’s top public health agency was plunged into chaos on Wednesday after the Trump administration...
Vinay Prasad, a top vaccine regulator ousted from the Food and Drug Administration (FDA) late last...
